Dosage compensation in mammals: fine-tuning the expression of the X chromosome
- PMID: 16847345
- DOI: 10.1101/gad.1422906
Dosage compensation in mammals: fine-tuning the expression of the X chromosome
Abstract
Mammalian females have two X chromosomes and males have only one. This has led to the evolution of special mechanisms of dosage compensation. The inactivation of one X chromosome in females equalizes gene expression between the sexes. This process of X-chromosome inactivation (XCI) is a remarkable example of long-range, monoallelic gene silencing and facultative heterochromatin formation, and the questions surrounding it have fascinated biologists for decades. How does the inactivation of more than a thousand genes on one X chromosome take place while the other X chromosome, present in the same nucleus, remains genetically active? What are the underlying mechanisms that trigger the initial differential treatment of the two X chromosomes? How is this differential treatment maintained once it has been established, and how are some genes able to escape the process? Does the mechanism of X inactivation vary between species and even between lineages? In this review, X inactivation is considered in evolutionary terms, and we discuss recent insights into the epigenetic changes and developmental timing of this process. We also review the discovery and possible implications of a second form of dosage compensation in mammals that deals with the unique, potentially haploinsufficient, status of the X chromosome with respect to autosomal gene expression.
Similar articles
-
X-chromosome upregulation and inactivation: two sides of the dosage compensation mechanism in mammals.Bioessays. 2009 Jan;31(1):21-8. doi: 10.1002/bies.080149. Bioessays. 2009. PMID: 19153998 Review.
-
Sexual antagonism and the evolution of X chromosome inactivation.Evolution. 2008 Aug;62(8):2097-104. doi: 10.1111/j.1558-5646.2008.00431.x. Epub 2008 May 27. Evolution. 2008. PMID: 18507742
-
Dosage compensation of the active X chromosome in mammals.Nat Genet. 2006 Jan;38(1):47-53. doi: 10.1038/ng1705. Epub 2005 Dec 11. Nat Genet. 2006. PMID: 16341221
-
X inactivation Xplained.Curr Opin Genet Dev. 2007 Oct;17(5):387-93. doi: 10.1016/j.gde.2007.08.001. Epub 2007 Sep 14. Curr Opin Genet Dev. 2007. PMID: 17869504 Review.
-
The evolution of dosage-compensation mechanisms.Bioessays. 2000 Dec;22(12):1106-14. doi: 10.1002/1521-1878(200012)22:12<1106::AID-BIES8>3.0.CO;2-W. Bioessays. 2000. PMID: 11084626 Review.
Cited by
-
Sex Differences in Mouse Longevity and Responses to Geroprotective Drugs: Implications for Human Intervention.Public Policy Aging Rep. 2023 Nov 1;33(4):120-124. doi: 10.1093/ppar/prad026. eCollection 2023. Public Policy Aging Rep. 2023. PMID: 38155934 Free PMC article. No abstract available.
-
Genome-wide differences in DNA methylation changes in caprine ovaries between oestrous and dioestrous phases.J Anim Sci Biotechnol. 2018 Dec 4;9:85. doi: 10.1186/s40104-018-0301-x. eCollection 2018. J Anim Sci Biotechnol. 2018. PMID: 30524725 Free PMC article.
-
Female X-chromosome mosaicism for NOX2 deficiency presents unique inflammatory phenotype and improves outcome in polymicrobial sepsis.J Immunol. 2011 Jun 1;186(11):6465-73. doi: 10.4049/jimmunol.1100205. Epub 2011 Apr 18. J Immunol. 2011. PMID: 21502376 Free PMC article.
-
Replication timing as an epigenetic mark.Epigenetics. 2009 Feb 16;4(2):93-7. doi: 10.4161/epi.4.2.7772. Epub 2009 Feb 1. Epigenetics. 2009. PMID: 19242104 Free PMC article. Review.
-
DXZ4 chromatin adopts an opposing conformation to that of the surrounding chromosome and acquires a novel inactive X-specific role involving CTCF and antisense transcripts.Genome Res. 2008 Aug;18(8):1259-69. doi: 10.1101/gr.075713.107. Epub 2008 May 2. Genome Res. 2008. PMID: 18456864 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
